UK markets closed

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.5950+0.0250 (+1.59%)
At close: 04:00PM EDT
Major holders
Insider roster

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases00
SalesN/A0
Net shares purchased (sold)00
Total insider shares held805.33kN/A
% net shares purchased (sold)N/AN/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

WERNER MILTON H
Chief Executive Officer

Purchase at price 0.80 per share.Direct4,00016 Aug 20225,000

WERNER MILTON H
Chief Executive Officer

Purchase at price 0.98 per share.Direct4,88027 May 20225,000

WERNER MILTON H
Chief Executive Officer

Purchase at price 0.60 per share.Direct6,00020 May 202210,000

FRATTAROLI JOSEPH
Chief Financial Officer

Purchase at price 0.64 per share.Direct2,54319 May 20223,948

WERNER MILTON H
Chief Executive Officer

Conversion of Exercise of derivative security at price 2.02 per share.Direct44,14303 Jan 202221,853

WERNER MILTON H
Chief Executive Officer

Purchase at price 1.93 - 1.98 per share.Indirect46,55817 Nov 202123,589

WERNER MILTON H
Chief Executive Officer

Conversion of Exercise of derivative security at price 2.02 per share.Direct44,14317 Aug 202121,853

WERNER MILTON H
Chief Executive Officer

Conversion of Exercise of derivative security at price 0.38 per share.Direct16,60914 May 202143,707

FRATTAROLI JOSEPH
Chief Financial Officer

Conversion of Exercise of derivative security at price 10.00 per share.Indirect441,43028 Dec 202044,143